on a mobile?
vTap
    Loading...
 
 
Video
Japanese drug maker Daiichi Sankyo has put in a $4.6 billion bid to acquire a majority stake in India's largest drug maker, Ranbaxy. Aadil E...
5m 4s |
5 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
...Daiichi Sankyo Co.'s purchase of Ranbaxy Laboratories Ltd., the role of generic medicines in treating diseases and drug development in emerging markets. Japanese drugmaker Daiichi Sankyo said it ...
5 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Pharmaceutical company
Drug development
Theta role
Go to Feed to see what's new!
share
keep
 
 
585
Masaya Tamae of Daiichi Sankyo said Ranbaxy's product pipeline and geographical presence is attractive. Tamae told CNBC-TV18 that they will explore other options if the 20% open offer does not happen....
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
CNBC-TV18
CNBC
Go to Feed to see what's new!
share
keep
 
 
5235
Daiichi Sankyo will buy out the entire promoter stake of 35% in Ranbaxy Labs at Rs 737/sh, which will also be priced at Rs 737 per share, reports CNBC-TV18. Daiichi's stake buy in Ranbaxy will ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
CNBC-TV18
CNBC
Go to Feed to see what's new!
share
keep
 
 
13530
...id Daiichi Sankyo would get 50.1% stake in Ranbaxy. "Ranbaxy will turn into a debt free company post deal. About USD 440 million FCCBs will be converted into equity. The FCCB conversion, new ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
13005
Sharmila Joshi of Prabhudas Lilladher is of the view that Ranbaxy is looking good at current level. On the operation front Daiichi Sankyo should be able to leverage Ranbaxy acquisition and increase their footprint in the generic space. So that would ...
5 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Sharmila Tagore
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use